Prognostic markers of high-grade squamous intraepithelial lesions: the role of p16^INK4a and high-risk human papillomavirus

References

• Bonds L, Baker P, Gup C, Shroyer KR. Immunohistochemical localization of Cdc6 in squamous and glandular neoplasia of uterine cervix. Arch Pathol Lab Med 2002; 126: 1163–8
   Web of Science ®Google Scholar
• Sherman ME. Chapter 11: future directions in cervical pathology. J Natl Cancer Inst Monogr 2003; 31: 72–9
   Google Scholar
• Branca N, Ciotti M, Santini D, Di Bonito L, Giorgi C, Benedetto A, et al. p16(INK4a) expression is related to grade of CIN and high-risk Human papillomavirus but does not predict virus clearance after conization or disease outcome. Int J Gynecol Pathol 2004; 23: 354–65
   PubMed Web of Science ®Google Scholar
• Kruse AJ, Skaland I, Janssen EA, Buhr-Wildhagen S, Klos J, Arends MJ, et al. Quantitative molecular parameters to identify low-risk and high-risk early CIN lesions: role of markers of proliferative activity and differentiation and Rb availability. Int J Gynecol Pathol 2004; 23: 100–9
   PubMed Web of Science ®Google Scholar
• Schlecht NF, Kulaga S, Robitaille J, Ferreira S, Santos M, Miyamura RA, et al. Persistent human papillomavirus infection as a predictor of cervical intraepithelial neoplasia. JAMA 2001; 286: 3106–14
   PubMed Web of Science ®Google Scholar
• Kisseljov FL, Mazurenko NN, Volgareva GM, Kisseljova NP. Interaction between viral and cell genes in cervical tumors. Mol Biol 2004; 38: 224–32
   Web of Science ®Google Scholar
• Giarre M, Caldeira S, Malanchi I, Ciccolini F, Leão MJ, Tommasino M. Induction of pRb degradation by the Human papillomavirus type 16 E7 protein is essential to efficiently overcome p16INK4a imposed G1 cell cycle arrest. J Virol 2001; 75: 4705–12
   PubMed Web of Science ®Google Scholar
• Sano T, Oyama T, Kashiwabara K, Fukuda T, Takashi N. Expression status of p16 protein is associated with Human papillomavirus oncogenic potential in cervical and genital lesions. Am J Pathol 1998; 153: 1741–8
   PubMed Web of Science ®Google Scholar
• Sharpless N, Alson S, Chan S, Silver DP, Castrillon DH, DePinho RA. p16INK4a and p53 deficiency cooperate in tumorigenesis. Cancer Res 2002; 62: 2761–5
   PubMed Web of Science ®Google Scholar
• Virmani AK, Muller C, Rathi A, Zoechbauer-Mueller S, Mathis M, Gazdar AF. Molecular oncology, markers, clinical correlates–aberrant methylation during cervical carcinogenesis. Clin Cancer Res 2001; 7: 584–9
   PubMed Web of Science ®Google Scholar
• Lin Z, Gao M, Zhang X, Kim YS, Lee S, Kim HK, et al. The hypermethylation and protein expression of p16INK4a and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions. J Cancer Res Clin Oncol 2005; 131: 364–70
   PubMed Web of Science ®Google Scholar
• Wang JL, Zheng BY, Li XD, Angstrom T, Lindstrom MS, Wallin KL. Predictive significance of the alterations of p16INK4a, p14ARF, p53 and proliferating cell nuclear antigen expression in the progression of cervical cancer. Clin Cancer Res 2004; 10: 2407–14
   PubMed Web of Science ®Google Scholar
• Guimarães MC, Gonçalves MA, Soares CP, Bettini JS, Duarte RA, Soares EG. Immunohistochemical expression of p16INK4a and bcl-2 according to HPV type and to the progression of cervical squamous intraepithelial lesions. J Histochem Cytochem 2005; 53: 509–16
   PubMed Web of Science ®Google Scholar
• Keating JT, Cviko A, Riethdorf S, Riethdorf L, Quade BJ, Sun D, et al. Cyclin E and p16INK4a are complimentary surrogate biomarkers for human papilloma virus-related cervical neoplasia. Am J Surg Pathol 2001; 25: 884–91
   PubMed Web of Science ®Google Scholar
• Klaes R, Benner A, Friedrich T, Ridder R, Herrington S, Jenkins D, et al. p16INK4a immunohistochemistry improves interobserver agreement in the diagnosis of cervical intraepithelial neoplasia. Am J Surg Pathol 2002; 26: 1389–99
   PubMed Web of Science ®Google Scholar
• Murphy N, Ring M, Killalea AG, Uhlman V, O'Donovan M, Mulcahy F, et al. p16INK4a as a marker for cervical dyskariosis: CIN and cGIN in cervical biopsies and thinprep smears. J Clin Pathol 2003; 56: 56–63
   PubMed Web of Science ®Google Scholar
• Negri G, Vitadello F, Romano F, Kasal A, Girlando S, Mian C, et al. p16INK4a expression and progression risk of low grade intraepithelial neoplasia of the cervix uteri. Virchows Arch 2004; 445: 616–20
   PubMed Web of Science ®Google Scholar
• Volgareva G, Zavalishina L, Andeeva Y, Frank G, Krutikova E, Golovina D, et al. Protein p16 as a marker of displastic alterations in cervical epithelial cells. BMC Cancer 2004; 4: 58–68
   PubMed Web of Science ®Google Scholar
• Nasiell K, Nasiell M, Vaclavinkova V. Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 1983; 61: 609–14
   PubMed Web of Science ®Google Scholar